
ÀÌÀ±Á¤ ±³¼ö


±Þ¼º ¹× ¸¸¼º °£¿°, °£¾Ï, ¾ËÄڿüº °£Áúȯ, Áö¹æ°£(´ë»çÀÌ»ó Áö¹æ°£Áúȯ), °£°æº¯Áõ ¹× ÇÕº´Áõ °ü¸®, °£ÀÌ½Ä ÀüÈÄ °ü¸®, À§/´ëÀå ³»½Ã°æ
| Áø·á½Ã°£ | ¿ù | È | ¼ö | ¸ñ | ±Ý | Åä |
|---|---|---|---|---|---|---|
| ¿ÀÀü | ¼¾ÅÍÁø·á | ¼¾ÅÍÁø·á | ¼¾ÅÍÁø·á | |||
| ¿ÀÈÄ | ¼¾ÅÍÁø·á |
¼¿ï´ëÇб³ Çлç Á¹¾÷ °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø Á¹¾÷ |
°í·Á´ëÇб³¾È»êº´¿ø ³»°ú Àü°øÀÇ ºÐ´ç¼¿ï´ëÇб³º´¿ø ¼Òȱ⳻°ú ÀüÀÓÀÇ ¹Ì±¹ ´º¿å ¸¶¿îÆ®½Ã³ªÀ̺´¿ø °£ÀÌ½Ä ¹× °£Áúȯ ½ÉÈ ÀüÀÓÀÇ(Advanced Fellowship) ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ¼Òȱ⳻°ú Áø·áÁ¶±³¼ö |
´ëÇѰ£ÇÐȸ ȸ¿ø ¹Ì±¹°£ÇÐȸ(AASLD) ȸ¿ø ¹Ì±¹À̽ÄÇÐȸ(AST) ȸ¿ø º¹ºÎÃÊÀ½ÆÄ ¼¼ºÎÀü¹®ÀÇ ¼Òȱ⳻½Ã°æ ¼¼ºÎÀü¹®ÀÇ ¹Ì±¹ Echosens»ç °£¼¶À¯È°Ë»ç (FibroScan) ÀÎÁõ (Operator/Provider Certification) |
|
³í¹® 1. 2025 Lee, Yunjeong, et al. ¡°Efficacy of Radiotherapy in combination with Immune checkpoint blockade for hepatocellular carcinoma and portal vein tumor thrombosis.¡± The Korean Journal of Medicine. 2. 2021 Lee, Yunjeong, et al. "Extraintestinal Manifestation of Yersinia pseudotuberculosis Bacteremia as Acute Hepatitis: Case Report and Review of the Literature." Pathogens. Çмú¹ßÇ¥ 1. 2024.06 À¯·´°£ÇÐȸ (EASL Congress 2024, ÀÌÅ»¸®¾Æ ¹Ð¶ó³ë): "External beam radiation therapy improves the response to Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma with portal vein tumor thrombosis." 2. 2023.11 ¹Ì±¹°£ÇÐȸ (The Liver Meeting 2023, ¹Ì±¹ º¸½ºÅÏ): "Nucleos(t)ide Analogues Help Preserve Liver Volume in Chronic Hepatitis B Patients with Low Viral Load." 3. 2023.11 ¹Ì±¹°£ÇÐȸ (The Liver Meeting 2023, ¹Ì±¹ º¸½ºÅÏ): "Predictors of Hepatitis Flare and Initiation of Antiviral Therapy in Nucleos(t)ide Naïve Chronic Hepatitis B in Grey Zone." 4. 2023.11 ¹Ì±¹°£ÇÐȸ (The Liver Meeting 2023, ¹Ì±¹ º¸½ºÅÏ): "Does Senescent Change in Spleen Affect Splenomegaly in Elderly Patients with Liver Cirrhosis." |